ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
BioAge Labs Inc

BioAge Labs Inc (BIOA)

5.23
-0.10
( -1.88% )
Updated: 04:13:28

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
5.23
Bid
5.20
Offer
5.24
Volume
24,676
5.135 Day's Range 5.32
3.85 52 Week Range 26.62
Market Cap
Previous Close
5.33
Open
5.28
Last Trade
2
@
5.2149
Last Trade Time
04:13:34
Financial Volume
US$ 129,301
VWAP
5.2399
Average Volume (3m)
789,910
Shares Outstanding
35,848,738
Dividend Yield
-
PE Ratio
-2.92
Earnings Per Share (EPS)
-1.78
Revenue
-
Net Profit
-63.85M

About BioAge Labs Inc

BioAge Labs is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Our technology platform and differentiated human datasets enable us to identify promising targets based on insights in... BioAge Labs is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Our technology platform and differentiated human datasets enable us to identify promising targets based on insights into molecular changes that drive aging. Azelaprag, our lead product candidate, demonstrated the ability to more than double the weight loss induced by a glucagon-like-peptide-1 receptor (GLP-1R) agonist while also restoring healthy body composition and improving muscle function in preclinical obesity models. These preclinical results are supported by our Phase 1b clinical trial in older adults on bed rest where we observed decreased muscle atrophy, preservation of muscle quality and improved metabolism in subjects treated with azelaprag over a 10-day period. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Newark, Delaware, USA
Founded
-
BioAge Labs Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BIOA. The last closing price for BioAge Labs was US$5.33. Over the last year, BioAge Labs shares have traded in a share price range of US$ 3.85 to US$ 26.62.

BioAge Labs currently has 35,848,738 shares in issue. The market capitalisation of BioAge Labs is US$191.07 million. BioAge Labs has a price to earnings ratio (PE ratio) of -2.92.

BIOA Latest News

The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA

The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA PR Newswire NEW YORK, Jan. 20, 2025 NEW YORK, Jan. 20, 2025...

BioAge Labs, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - BIOA

BioAge Labs, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - BIOA PR Newswire NEW YORK, Jan. 16, 2025 NEW YORK, Jan. 16, 2025...

BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - BIOA

BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 10, 2025 to Discuss Your Rights - BIOA PR Newswire NEW YORK, Jan. 13, 2025 NEW YORK, Jan...

Class Action Filed Against BioAge Labs, Inc. (BIOA) - March 10, 2025 Deadline to Join - Contact The Gross Law Firm

Class Action Filed Against BioAge Labs, Inc. (BIOA) - March 10, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire NEW YORK, Jan. 9, 2025 NEW YORK, Jan. 9, 2025 /PRNewswire/ -- The...

BIOA INVESTOR ALERT: Edelson Lechtzin LLP Urges BioAge Labs, Inc. (NASDAQ: BIOA) Shareholders to Consult Legal Counsel About the Impending Lead Plaintiff Deadline in the Securities Fraud Class Action

BIOA INVESTOR ALERT: Edelson Lechtzin LLP Urges BioAge Labs, Inc. (NASDAQ: BIOA) Shareholders to Consult Legal Counsel About the Impending Lead Plaintiff Deadline in the Securities Fraud Class...

BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions

Collaboration will leverage BioAge's differentiated human longevity data and platform and Novartis expertise in the biology of physical exercise to identify drug targets to treat diseases related...

BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity

Decision follows observations of liver transaminitis without clinically significant symptoms in some subjects on azelaprag Company will evaluate data from patients enrolled to date and share...

BioAge Labs to Present at Goldman Sachs “Year-Ahead” Catalyst Clinic

RICHMOND, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for...

BioAge Labs to Present at Upcoming Investor Conferences

RICHMOND, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for...

BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates

Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesity Completed $238.3 million initial public offering and concurrent private placement, cash and cash...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.5311.27659574474.75.384.42931195.05930562CS
4-0.77-12.833333333366.474.44071765.34793095CS
12-19.57-78.911290322624.825.33.857899107.3280678CS
26-17.27-76.755555555622.526.623.8569771910.35626766CS
52-17.27-76.755555555622.526.623.8569771910.35626766CS
156-17.27-76.755555555622.526.623.8569771910.35626766CS
260-17.27-76.755555555622.526.623.8569771910.35626766CS

BIOA - Frequently Asked Questions (FAQ)

What is the current BioAge Labs share price?
The current share price of BioAge Labs is US$ 5.23
How many BioAge Labs shares are in issue?
BioAge Labs has 35,848,738 shares in issue
What is the market cap of BioAge Labs?
The market capitalisation of BioAge Labs is USD 191.07M
What is the 1 year trading range for BioAge Labs share price?
BioAge Labs has traded in the range of US$ 3.85 to US$ 26.62 during the past year
What is the PE ratio of BioAge Labs?
The price to earnings ratio of BioAge Labs is -2.92
What is the reporting currency for BioAge Labs?
BioAge Labs reports financial results in USD
What is the latest annual profit for BioAge Labs?
The latest annual profit of BioAge Labs is USD -63.85M
What is the registered address of BioAge Labs?
The registered address for BioAge Labs is 131 CONTINENTAL DRIVE, SUITE 301, NEW CASTLE, NEWARK, DELAWARE, 19713
What is the BioAge Labs website address?
The website address for BioAge Labs is www.bioagelabs.com
Which industry sector does BioAge Labs operate in?
BioAge Labs operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BLBXBlackBoxStocks Inc
US$ 3.295
(94.97%)
127.69M
STAIScanTech AI Systems Inc
US$ 2.2607
(53.79%)
17.18M
ASSTAsset Entities Inc
US$ 1.325
(47.22%)
107.84M
TOIIWOncology Institute Inc
US$ 0.0235
(38.24%)
67.75k
NTRBNutriband Inc
US$ 6.94
(33.21%)
2.78M
AALAmerican Airlines Group Inc
US$ 18.64
(0.00%)
81.8k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.3208
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.02
(0.00%)
1.01k
AACGATA Creativity Global
US$ 0.94
(0.00%)
66
IPAImmunoPrecise Antibodies Ltd
US$ 0.493
(0.00%)
49.22M
ASSTAsset Entities Inc
US$ 0.90
(0.00%)
36.72M
RIMEAlgorhythm Holdings Inc
US$ 0.0346
(0.00%)
16.13M
CDIOCardio Diagnostics Holdings Inc
US$ 0.608
(0.00%)
14.04M
NEHCNew Era Helium Inc
US$ 2.74
(0.00%)
11.95M

Discussion

View Full Feed
linkvest linkvest 2 minutes ago
It hard to believe that we can still buy a quality stock like ASII for .0005 LMAO.... This is like the old days. Buy low and cheap and watch it run to they moon.....
ASII
LTListener LTListener 2 minutes ago
I agree. How many penny stocks have you ever seen that has government funding a phase 2 clinical trial AND another in a government funded preclinical program where all indications are it has been highly successful AND then the penny stock suddenly went quiet when BOD and execs have a history of amp
RSPI
Prudent Capitalist Prudent Capitalist 2 minutes ago
Exactly. They settled all of the charges regarding scripts for Opioids. How many times are retail pharmacies going to have to spend money defending claims that they filled prescriptions received from license physicians? And surgeons are still prescribing Oxycodone and Hydrocodone to patients foll
WBA
gitreal gitreal 2 minutes ago
But hey, the U of Alaska will study the meteorite impact theory!! Isn't that enough for you?
SDRC
Peter F1 Peter F1 2 minutes ago
wow, anyone else seeing this? This seems huge! LXRX...
LXRX
Investor082 Investor082 3 minutes ago
Agreed. And it won’t stop in 2025. It will continue in 2026 as well.
NWBO
Curt D Curt D 3 minutes ago
Unfortunately, this good news most likely won't silence the pathetic posters we have here.
RDAR
Hardazoak Hardazoak 3 minutes ago
Do proper dd orange dave, stockpile agreement filed with Mexican mining registry.
AABB
Stinger2014 Stinger2014 3 minutes ago
Hey 316! I know…..but have no other reason! lol 😝
CGAC
facts_matter14 facts_matter14 3 minutes ago
Stuck holding bags that are 99% less than they were on 2-12-21 is a sign of 🗑️

Rosetta Stone for English…….








.


.
SRMX
SoxFan SoxFan 3 minutes ago
Not for a Supreme Court justice. Just 51
crowin crowin 3 minutes ago
The PR is called a carrot on a stick
RDAR
MC10459 MC10459 3 minutes ago
I don't see anything in my Schwab account.
BDPT
Hardazoak Hardazoak 4 minutes ago
Yes so it can be shown that there are thousands and thousands of complaints from aabb investors about naked shorting and manipulation of aabb stock. Trust me this not a good thing for Bashers or dirty rotten market makers, exposure of so many complaints and no action by SEC will force thwm to take a
AABB
gitreal gitreal 4 minutes ago
So you admit there is no audit, and never will be? How you gonna uplist without one?
BMXI
wickerman wickerman 4 minutes ago
$HOLO this dilution should help it get there faster.
Their fake press releases are kind of fun to decipher.

https://www.sec.gov/Archives/edgar/data/1841209/000182912625000246/microcloud_424b5.htm
HOLO
gdog gdog 4 minutes ago
lol let me keep them for a few more days first without food :+)
NLST
koolmc koolmc 4 minutes ago
74's :) adidas recent earning bodes well for rest of the apparel sector and nke going along for the ride
NKE
nwsun nwsun 4 minutes ago
The following is Deep Power's address

DeepPower, Inc.
1633 W Innovation Way
4th floor
Lehi, UT 84043

I called up another business listed in that bldg. Asked the person if there was a business named Deep Power on the 4th floor. She said the bldg doe
SFLM
DiscoverGold DiscoverGold 5 minutes ago
Commodities Daily Market Movers (% Price Change)
By: Marty Armstrong | January 22, 2025

• Top Movers

NY Natural Gas Futures 4.29 %
Cheese 3.85 %
White Sugar ICE Futures 2.65 %
LBMA Silver in USD 2.37 %
US - Gold/Crude Ratio
OILBRENT
Penny Stocks 2.0 Penny Stocks 2.0 5 minutes ago
$UNQL .0076 Up She's Running 
UNQL
Curt D Curt D 5 minutes ago
Great news! Right on time again. It will be very interesting to see what comes after the Microcap Conference next week.
RDAR
Sodapop42 Sodapop42 5 minutes ago
Take care of what? He lost by not answering the complaint. There is no settlement. He has no money. What's he going to take care of it with? Hell he might have a criminal referral to the DOJ.
PHIL
Penny Stocks 2.0 Penny Stocks 2.0 5 minutes ago
$UNQL .0076 Up She's Running 
UNQL

Your Recent History

Delayed Upgrade Clock